A 35-year-old man presents with a painless, flesh-coloured, warty growth on his penis that has been present for 8 months. He reports multiple sexual partners and inconsistent condom use. Physical examination reveals a 1.5 cm exophytic lesion on the glans penis with a cauliflower-like appearance. HPV PCR testing is positive for HPV-6 and HPV-11. The patient asks about his risk of developing penile cancer. Based on the HPV types identified, what is the most appropriate counselling regarding malignant transformation?

Explanation

## HPV-6 and HPV-11: Low-Risk Types **Key Point:** HPV-6 and HPV-11 are low-risk (non-oncogenic) HPV types that cause benign genital warts and have virtually no malignant potential (<1% risk of progression to cancer). ### Classification of HPV Types | HPV Type | Risk Category | Associated Lesions | Malignant Potential | Examples | |----------|---------------|-------------------|-------------------|----------| | 6, 11, 42, 43, 44 | Low-risk | Genital warts, RRP | <1% | Benign condyloma acuminata | | 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | High-risk | CIN, cancer | 10-30%+ | Cervical, anal, oropharyngeal cancer | ### Natural History of Genital Warts (HPV-6/11) 1. **Incubation period:** 3 weeks to 8 months (patient at 8 months) 2. **Clinical presentation:** Exophytic, cauliflower-like lesions (as in this case) 3. **Spontaneous regression:** 20-30% regress within 6 months without treatment 4. **Persistence:** 30% persist unchanged; 40% progress in size 5. **Malignant transformation:** Extremely rare; <1% of cases **High-Yield:** The distinction between low-risk (6, 11) and high-risk (16, 18) HPV is the MOST important concept in HPV virology for NEET PG. Low-risk types cause warts; high-risk types cause cancer. ### Management of This Patient **Clinical Pearl:** Genital warts are primarily a cosmetic and symptomatic concern, not a cancer precursor when caused by HPV-6/11. Treatment options include: - Observation (many regress spontaneously) - Topical agents: imiquimod, podophyllotoxin, sinecatechins - Ablative procedures: cryotherapy, laser, electrocautery - Surgical excision if large or symptomatic **Counselling Points:** - No increased cancer risk with HPV-6/11 - Lesions may regress spontaneously - Treatment is for symptom relief, not cancer prevention - Safe sex practices reduce transmission to partners - HPV vaccination (if not previously vaccinated) covers HPV-6/11 and high-risk types ### Why High-Risk Types Are Different HPV-16 and HPV-18 express E6 and E7 oncoproteins that inactivate p53 and Rb, leading to malignant transformation. HPV-6 and HPV-11 produce non-functional E6/E7 variants that do not cause transformation. [cite:Harrison 21e Ch 197; Park 26e Ch 24]